USPTO serial 88626826
APTIQ
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- PARK, JENNY K
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with APTIQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Aaron D. Hendelman
Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304-1050UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays and reagents for scientific or research use; reagent kits for preparation or performance of single molecule assays for scientific or research use; reagent kits comprising components for single molecule assays for scientific or research use; kits comprising primarily of reagents, enzymes and/or nucleotides for genetic research diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic test kits for scientific use comprising reagents, flowcells, microfluidic devices, data analysis software and support documentation, namely, instructional manuals, therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small- molecule analysis, single nucleotide polymorphisms analysis, insertion and deletion mutations, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, detection of genomic rearrangements and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small- molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; chemical reagents for scientific use; nucleic acid polymer particles for use in genetic sequencing | ACTIVE | — |
| 005 | Diagnostic preparations for medical and veterinary medical purposes, namely, for the preparation of samples, the modification and manipulation of samples and for the marking, separation, isolation, purification and reproduction and analysis of biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological products, namely, reagents and solvents for medical use for the preparation of samples, the modification and the manipulation of samples and for performing marking, separation, isolation, purification, reproduction and analysis methods for biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits comprising diagnostic preparations for medical and veterinary medical diagnostic purposes for the preparation of samples, the modification and manipulation of samples and for marking, separation, isolation, purification, reproduction and analysis of biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances in the nature of nucleic acids from biological or biochemical sample material diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily reagents, flowcells, solid matrix materials, microfluidic devices, downloadable or non-downloadable software for nucleic acid sequencing and analysis, monitoring and interpreting data from genome analyzer machines, and displaying, organizing, storing, sharing and interpreting DNA data sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, flowcells, solid matrix materials, microfluidic devices sold as a unit and instructional manuals therefor; medical diagnostic kits comprising medical diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type in the nature of equipment, namely, medical diagnostic immune-assays for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, insertion and deletion polymorphisms, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations and structural variants, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for diagnostics for a variety of uses in health care namely, medical diagnostic reagents for RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis, namely, reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes | ACTIVE | — |
| 009 | Laboratory instruments for scientific research, namely, optical detectors for genetic sequencing and biochemical analysis; scientific equipment and instruments, namely, semiconductor chips with integrated sensors for nucleic acid sequencing, semiconductor chip readers and related downloadable or recorded computer software used for nucleic acid sequencing and analysis; genome analyzer machines and related downloadable or recorded computer operating software; downloadable or recorded computer software for monitoring of genome analyzer machines from handheld or mobile wireless communication devices capable of voice, data and/or image transmission; downloadable or recorded computer software for the interpretation of data from the genome analyzer machines; downloadable or recorded computer software for displaying, organizing, storing, sharing and interpreting of DNA data | ACTIVE | — |
| 042 | Computer services, namely, providing an online community for subscribers to participate by sharing and posting articles, videos, and other content, namely, findings in the fields of nucleic acid sequencing and genotyping, medical diagnostics, clinical diagnostics, medical research, clinical research, life sciences, biology, molecular diagnostics, laboratory medicine, biotechnology, agriculture, forensics, and genetics; research services, namely, case studies in the fields of and for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, metagenomics, biotechnology, agriculture, forensics, food safety, and genetics; leasing of laboratory equipment, namely, genomic sequencers and molecular diagnostics, scientific apparatus and instruments, namely, genomic sequencers and molecular diagnostics; medical research services in the field of genotyping, diagnostics, molecular pathology, molecular diagnostics, laboratory medicine, and oncology; DNA sequencing, screening, and analysis services for research purposes; DNA sequencing, screening, and analysis services for use in agricultural, environmental and forensic applications; DNA sequencing, screening, and analysis services for medical research purposes; nucleic acid sequencing, screening, and analysis services for medical research purposes; genomic sequencing, screening, and analysis services for medical research purposes; genetic analysis and reporting services for medical research purposes; providing temporary use of nondownloadable software for displaying, organizing, storing, sharing and interpreting of DNA data; genomic sequencing, screening, and analysis services for non-medical purposes; nucleic acid sequencing, screening, and analysis services for non-medical diagnostic purposes; genetic analysis and reporting services for non-medical purposes; providing temporary use of nondownloadable software for interpretation of data from genome analyzer machines | ACTIVE | — |
| 044 | Medical testing for diagnostic or treatment purposes; DNA sequencing, screening, and analysis services for medical diagnostic purposes; nucleic acid sequencing, screening, and analysis services for medical diagnostic purposes; genomic sequencing, screening, and analysis services for medical diagnostic purposes; genetic analysis and reporting services for medical diagnostic purposes; medical diagnostic testing, monitoring and reporting services in the field of infectious disease identification and surveillance | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Apton Biosystems, Inc.
- Other trademarks owned by Apton Biosystems, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named APTIQ
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 16, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 16, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 12, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 8, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 8, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 8, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 14, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 12, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 12, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 12, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 13, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 18, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 18, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 29, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 16, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 29, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 29, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 29, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 30, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 30, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 30, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 27, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 26, 2019 | NWAP | NEW APPLICATION ENTERED | — |